2,2,7-trimethyl-octane-3,6-dione | 62141-56-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2,2,7-trimethyl-octane-3,6-dione
• 英文别名: 2,2,7-Trimethyloctane-3,6-dione
• CAS: 62141-56-4
• 化学式: C₁₁H₂₀O₂
• 分子量: 184.279
• InChiKey: MPDMIKOVNNMRJW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  34.1
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  (1-isopropyl-vinyl)-dimethyl-amine 、 1-溴频哪酮 生成 2,2,7-trimethyl-octane-3,6-dione
  参考文献：
  名称：

  Nilsson,L.; Rappe,C., Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry, 1976, vol. 30, p. 1000 - 1001

  摘要：

  DOI：

文献信息

• CHITOSAN COVALENTLY LINKED WITH SMALL MOLECULE INTEGRIN ANTAGONIST FOR TARGETED DELIVERY
  申请人：Hoffmann-La Roche Inc.

  公开号：US20130197205A1

  公开（公告）日：2013-08-01

  The invention relates to the chitosan polymer derivatives of formula I: and pharmaceutically acceptable salts and esters thereof, wherein Y, X 1 , X 4 , R1, R2, and n are defined in the detailed description and claims. The chitosan polymer derivatives of formula I bind to or associate with alpha-4-beta-1 (α4β1) and alpha-V-beta-3 (αVβ3) integrin dimers and can be used in delivery formulations to deliver drugs, nucleic acids, or other therapeutic compounds to tissues or cells expressing such integrins.

  该发明涉及公式I的壳聚糖聚合物衍生物： 及其药用可接受的盐和酯，其中Y、X 1 、X 4 、R1、R2和n在详细说明和权利要求中有定义。公式I的壳聚糖聚合物衍生物与α4β1和αVβ3整合素二聚体结合或结合，并可用于传递制剂以将药物、核酸或其他治疗化合物传递到表达这些整合素的组织或细胞中。
• Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them
  申请人：RUDOLF Klaus

  公开号：US20070208036A1

  公开（公告）日：2007-09-06

  The present invention relates to compounds of general formula R-Z 1 -Z 2 -Z 3 -R  (I), wherein R, R 1 and Z 1 to Z 3 are defined as in claim 1 , the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, which have valuable pharmacological properties, particularly CGRP-antagonistic properties, pharmaceutical compositions containing these compounds, their use and processes for preparing them.

  本发明涉及一般式R-Z1-Z2-Z3-R(I)的化合物，其中R、R1和Z1至Z3如权利要求1所定义，其互变异构体、对映异构体、立体异构体、其混合物及其与无机或有机酸或碱的生理上可接受的盐，特别是具有有价值的药理学性质，特别是CGRP-拮抗性质的药物组合物，包含这些化合物，它们的用途和制备它们的过程。
• METHIONINE ANALOGS AND METHODS OF USING SAME
  申请人：Bassiri Mansour

  公开号：US20110196014A1

  公开（公告）日：2011-08-11

  Provided are methionine analogs which may be useful for inhibiting protein synthesis, inhibiting microbial growth and/or treating infectious diseases. In some instances, the analogs exhibit bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and/or antiviral properties. Also provided are methods of treatment and methods of preparation, as well as kits and unit dosages.

  提供的是蛋氨酸类似物，可用于抑制蛋白质合成，抑制微生物生长和/或治疗传染病。在某些情况下，这些类似物表现出杀菌、抗菌、抗感染、抗微生物、杀孢子、消毒、抗真菌和/或抗病毒的特性。还提供了治疗方法和制备方法，以及套件和单位剂量。
• BIOADHESIVE COMPOUNDS AND METHODS OF SYNTHESIS AND USE
  申请人：Lee Bruce P.

  公开号：US20120016390A1

  公开（公告）日：2012-01-19

  The invention describes new synthetic medical adhesives and antifouling coatings which exploit the key components of natural marine mussel adhesive proteins.
• PROLINE-LOCKED STAPLED PEPTIDES AND USES THEREOF
  申请人：President and Fellows of Harvard College

  公开号：US20150239937A1

  公开（公告）日：2015-08-27

  The present invention provides a new type of alpha-helix nucleating cross-link (“staple”) formed by olefin metathesis of a proline derivative with an alkenyl side chain and another amino acid derivative with an alkenyl side chain. The proline derivatives as described herein have been found to be strong nucleators of alpha-helix formation. The invention also provides moieties for shielding the free amide N—H's at the N-terminus of an alpha-helix, thereby further stabilizing the helix. The proline derivatives, precursors prior to cross-linking, and the cross-linked peptides are provided as well as methods of using and preparing these compounds and peptides.